ONTRONOS Trademark

Trademark Overview


On Friday, November 21, 2014, a trademark application was filed for ONTRONOS with the United States Patent and Trademark Office. The USPTO has given the ONTRONOS trademark a serial number of 86461268. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 28, 2022. This trademark is owned by Glaxo Group Limited. The ONTRONOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardio...
ontronos

General Information


Serial Number86461268
Word MarkONTRONOS
Filing DateFriday, November 21, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 28, 2022
Registration Number4776550
Registration DateTuesday, July 21, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ONTRONOS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, January 28, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, July 21, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 21, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 1, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 31, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 31, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 31, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 31, 2015ASSIGNED TO LIE
Tuesday, March 24, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 10, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 10, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, March 10, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 10, 2015ASSIGNED TO EXAMINER
Saturday, November 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 25, 2014NEW APPLICATION ENTERED IN TRAM